Appukkuttan S, Farej R, Miles L, Purser M, Wen L. Budget-impact of adding darolutamide to a United States payer formulary for non-metastatic castration-resistant prostate cancer. Poster presented at the 2020 AMCP (Conference cancelled); April 21, 2020. Houston, TX. [abstract] J Manag Care Pharm. 2020 Apr 20; 26(4-a):S18.
Aggarwal K, Vredenburg M, Mladsi D, Barnett C. Cost-effectiveness of avatrombopag for the treatment of thrombocytopenia in patients with chronic liver disease. Poster presented at the 2020 AMCP Meeting (Conference cancelled); April 2020. [abstract] J Manag Care Pharm. 2020 Apr; 26(Supplement 4a):s58.
Obimah A, Goyal RK, Bhansali A, Sansgiry SS. Can intervention tools with better message framing lead to better intention: a case of chemoprevention for breast cancer. Poster presented at the 2020 AMCP (Conference cancelled); April 2020. Houston, TX. [abstract] J Manag Care Pharm. 2020 Apr; 26(4-a):S89.
Parikh R, Niyazov A, Esterberg E, Arondekar B, Arruda L, Obeid E. Real-World treatment patterns and safety outcomes among patients with HER2 negative advanced breast cancer and BRCA1/2 mutations: evidence from a retrospective medical record review study in the United States. Poster presented at the 2020 AMCP (Conference cancelled); April 21, 2020. Houston, TX. [abstract] J Manag Care Pharm. 2020 Apr; 26(4-a):S16.
Thach A, Sutphin J, Coulter J, Mansfield C. Patient experiences and preferences for specific on-demand treatments for Parkinson's Disease-related “OFF” episodes. Poster presented at the 2020 AMCP (Conference cancelled); April 21, 2020. Houston, TX. [abstract] J Manag Care Pharm. 2020 Apr; 26(4-a):S40.